Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Sven H. Loosen(Düsseldorf University Hospital), Christoph Roderburg(Universitätsklinikum Aachen), Georg Wiltberger(University Hospital Leipzig), Pia Paffenholz(University Hospital Cologne), Jakob Nikolas Kather(Heidelberg University), Tom Luedde(Düsseldorf University Hospital), Alexander Koch(RWTH Aachen University), Mihael Vucur(Düsseldorf University Hospital), Frank Tacke(Charité - Universitätsmedizin Berlin), Ulf P. Neumann(RWTH Aachen University), Georg Lurje(Charité - Universitätsmedizin Berlin), Florian Ulmer(Universitätsklinikum Aachen), Christian Trautwein(TUM Klinikum)
Cited by 56
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
|Nature Reviews Gastroenterology & Hepatology|2011|1.4k